Female Urogenital Diseases and Pregnancy Complications

217 trials 111 recruiting

Filter these 217 trials by phase, country and sponsor.

Open in Search →

A phase II/III multi-centre, open-label, parallel group study to prove the non-inferiority of safety and efficacy of Metronidazole/Neomycin … Halted

2024-518862-28-00 female patients with bacterial vaginosis (BV), respecti 10 2024-11-19
A Study of Glucothera Plus for Peritoneal Dialysis in Children (ASTRA) Halted

2024-512078-88-00 End-stage Kidney Disease 5 2024-04-29
Induction chemotherapy followed by standard concurrent chemoradiotherapy in cervical cancer with para-aortic lymph node involvement: A phase… Halted

2024-513576-18-00 Cervical Cancer 5 2020-07-17
The pilot bioavailability study comparing the absorption of carbetocin (which is used as prevention of heavy bleeding after childbirth) in P… Ended

2025-524768-39-00 Not applicable (submitted trial is a bioavalability stu 2 2026-03-13
A randomized, three-period, single-dose crossover trial in healthy female volunteers to demonstrate bioequivalence of tafoxiparin following … Ended

2025-521140-38-00 Labor priming 2 2026-02-11
Investigation of 3 different doses of a newly developed vaginal ring releasing estriol for the treatment of vaginal atrophy - a placebo-cont… Ended

2024-514302-31-00 Vaginal atrophy 4 2025-07-16
A Phase I, randomized, controlled, Latin-square, open-label study, to evaluate the effect of ADV7103 on gastric pH under fed and fasting con… Ended

2024-518764-13-00 distal renal tubular acidosis (dRTA) 3 2025-02-25
A Single Dose, Fast state, Crossover Replicate Bioequivalence Study of NITROFURANTOIN 100 mg prolonged-release capsules (IASIS PHARMA) vs.FU… Ended

2024-517967-22-00 healthy subjects 2 2025-02-25
Phase 1 first-in-human, single and multiple dosing study of FB301 in healthy female subjects Ended

2024-517539-38-00 Women infertility 1 2025-02-13
A Study to Investigate the Pharmacokinetics, Safety and Tolerability of AZD5462 in Participants with Renal Impairment Ended

2024-514359-14-00 Impaired renal function 3 2024-11-18
Efficacy, safety, and dose-response of a Live Biotherapeutic Product (BGY-1601-VT, vaginal tablet) as a first-line monotherapy in women with… Ended

2023-508958-26-00 Gynaecological 7 2024-10-16
ImmunoTHerapy Adjacent to Cervical CAncer (ITHACA) study: safety, toxicity and immunological effects of peritumorally delivered immunotherap… Ended

2023-505968-11-00 Cervical Cancer 3 2024-10-15
A phase 2b dose finding study of RMC-035 in participants undergoing open-chest cardiac surgery Ended

2024-510658-28-00 Loss of renal function following cardiac surgery 4 2024-09-24
The impact of the intensity of ovarian stimulation on embryo quality in predicted suboptimal responders. A randomized controlled trial. Ended

2024-514322-23-00 infertility 6 2024-09-09
An exploratory study to investigate the effect of FE 999302 when given during different time periods to women undergoing controlled ovarian … Ended

2023-508149-42-00 Infertility in women undergoing assisted reproductive t 3 2024-07-16
An exploratory study to investigate the effect of FE 999302 when given together with follitropin delta during controlled ovarian stimulation Ended

2023-507630-25-00 Infertility in women undergoing assisted reproductive t 3 2024-06-14
Short-term GnRH- Antagonist Treatment to Lower LH Pulsatility in Women With PCOS Aiming to Improve Hormonal Functions - SOPKGANI Ended

2024-514102-32-00 Polycystic ovarian 1 2024-04-17
Brain effects of hormonal contraceptives. Ended

2023-507842-10-00 Contraception 6 2024-03-18
A study to learn about how elinzanetant works and how safe it is in women having sleep disturbances associated with menopause Ended

2023-504955-28-01 Sleep disturbances associated with menopause 4 2024-03-14
Feasibility and tolerability of 28 days intravaginal oxybutynin via the MedRing OAB system Ended

2023-508692-36-00 Overactive bladder 3 2024-02-06
A study to investigate efficacy and safety of OG-6219 twice a day in 3 dose levels compared with Placebo in participants aged 18 to 49 with … Ended

2022-501310-57-00 Endometriosis related pain 4 2024-02-05
Ilofotase alfa for prevention of renal damage after cardiac surgery Ended

2023-505859-45-00 Risk for renal damage following open heart surgery 4 2023-12-19
A randomized controlled trial comparing sequential of two shots of CFA vs CFA + rFSH for Elective Fertility Preservation. The 2-shot protoco… Ended

2023-506162-31-00 Infertility 5 2023-12-12
Contribution of PET (positron emission tomography) scans for the preoperative assessment of symptomatic endometriosis lesions: TEP-ENDORUN Ended

2024-520423-88-00 Endometriosis 5 2023-12-12